Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
Clinical trial NCT02878083 · TERMINATED
Trial details
- NCT number
- NCT02878083
- Sponsor
- Nantes University Hospital
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-11
- Primary completion
- 2020-01-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.